Title

奈米鑽石刀獵殺癌症細胞之分子機制

Translated Titles

Molecular mechanism study of growth hormone conjugated nanodiamonds in cancer cell hunting and eliminating

DOI

10.6842/NCTU.2009.00586

Authors

周靖淳

Key Words

奈米鑽石 ; 肺腺癌細胞 ; 標靶治療 ; nanodiamond ; A549 ; target therapy

PublicationName

交通大學生物科技系所學位論文

Volume or Term/Year and Month of Publication

2009年

Academic Degree Category

碩士

Advisor

張家靖

Content Language

繁體中文

Chinese Abstract

現今奈米生物科技是個很熱門的研究領域,主要是因為當某材料的空間中尺寸達到100 nm以下時,其物理及化學特性相較於一般塊材會有所改變,而奈米鑽石也不例外。早期的奈米鑽石多用於機械上的工業加工或是表面處理,但有近來之研究發現奈米鑽石具有螢光特性,可當作生物分子的追蹤器(bio-tracer);並有其他文獻指出奈米鑽石不具有細胞毒性且能進行表面官能基的修飾,因此奈米鑽石更具有跨足生醫領域的潛能。而奈米鑽石在吸收奈秒脈衝雷射能量後,其內部的官能基會由-C-N=O裂解成-C ﹢N≡O,更近一步來說,也就是奈米鑽石吸收了能量產生了熱聲子效應,使得鑽石間的軌域由鑽石的核心結構sp3轉變成石墨的結構sp2就由如爆炸一般。因此利用奈米鑽石吸收能量具有爆炸的特性,且結合一生長激素蛋白,使具有大量表現生長激素受體的癌症細胞與奈米鑽石-生長激素附合體結合,再搭配雷射能量系統使得奈米鑽石爆炸,並隨後引發一連串的細胞凋亡反應。而本實驗利用聲子所引起的奈米級爆炸,猶如奈米刀般應用在奈米級生物醫學治療上。

English Abstract

Nano biotechnology is a cutting edge reseach, recently. ”Nano” is definited the length under 100 nm and the physical and chemical properties are quite different than its bulk material. Nanodiamond (ND) surrounds with layers of graphite on its surface. This unique structure feature creates unusual fluorescence spectra which can be used as an indicator to monitor its surface modification. Meanwhile, it contains nitrosol (-C-N=O) inside the ND and this impurity can absorb nanosecond laser radiation to cleavage the -C-N=O chemical functional group into -C ﹢N≡O. Moreover, the NO gas molecules are heated by hot phonon of ND and generate huge pressure inside the diamond core to facilitate the sp3 diamond core transforming into sp2 graphite structure as a nano-blast. Therefore, the growth hormone receptor (GHR) of cell surface can be destroyed by growth hormone conjugated-ND (NDGH) and then be triggered the process of cell apoptosis. This photo-trigger nanoblast can be used as nano-knifes in nano-medicine application.

Topic Category 生物科技學院 > 生物科技系所
生物農學 > 生物科學
Reference
  1. 1. Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW: Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 2007, 150,552-558.
    連結:
  2. 2. Rusanov AI: Striking world of nanostructures. Russ. J. Gen. Chem. 2002, 72,495-511.
    連結:
  3. 3. Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113,823-839.
    連結:
  4. 5. Dobson J: Magnetic Nanoparticles for Drug Delivery. 2006, 67,6.
    連結:
  5. 6. Zheng XL, Lu JP, Deng L, Xiong Y, Chen JM: Preparation and characterization of magnetic cationic liposome in gene delivery. Int. J. Pharm. 2009, 366,211-217.
    連結:
  6. 7. Weidong D, Wei L, Gang C, Huimin C, Huayang T, Xianfa T, Qinghui J, Zhongwu S, Hui Z, Wenming Z, et al.: Detection of known base substitution mutations in human mitochondrial DNA of MERRF and MELAS by biochip technology. Biosens. Bioelectron. 2009, 24,2371-2376.
    連結:
  7. 8. Ramachandran PP, Christensen SM, Iqbal SM: Electronic detection of selective proteins using non antibody-based CMOS chip. In 2009 IEEE/NIH Life Science Systems and Applications Workshop (LiSSA 2009) 9-10 April; Bethesda, MD,: Ieee: 2009:1-4.
    連結:
  8. 9. Li Z, Xiang J, Zhang W, Fan S, Wu M, Li X, Li G: Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor model. Cancer Gene Ther. 2009, 16,423-429.
    連結:
  9. 10. Singh SR, Grossniklaus HE, Kang SJ, Edelhauser HF, Ambati BK, Kompella UB: Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther. 2009, 16,645-659.
    連結:
  10. 11. Hu XY, Jiang P, Xin C, Yang H, Gong QH: Nano-Ag:polymeric composite material for ultrafast photonic crystal all-optical switching. Appl. Phys. Lett. 2009, 94,3.
    連結:
  11. 12. Patel PA, Eckart J, Advincula MC, Goldberg AJ, Mather PT: Rapid synthesis of polymer-silica hybrid nanofibers by biomimetic mineralization. Polymer 2009, 50,1214-1222.
    連結:
  12. 13. Smith AM, Banwell EF, Edwards WR, Pandya MJ, Woolfson DN: Engineering increased stability into self-assembled protein fibers. Adv. Funct. Mater. 2006, 16,1022-1030.
    連結:
  13. 14. Yasuoka N, Kawaguchi K, Ebe H, Akiyama T, Ekawa M, Morito K, Sugawara M, Arakawa Y: Quantum-Dot Semiconductor Optical Amplifiers With Polarization-Independent Gains in 1.5-mu m Wavelength Bands. IEEE Photonics Technol. Lett. 2008, 20,1908-1910.
    連結:
  14. 15. Manzoor K, Johny S, Thomas D, Setua S, Menon D, Nair S: Bio-conjugated luminescent quantum dots of doped ZnS: a cyto-friendly system for targeted cancer imaging. Nanotechnology 2009, 20,13.
    連結:
  15. 16. Corrado C, Jiang Y, Oba F, Kozina M, Bridges F, Zhang JZ: Synthesis, Structural, and Optical Properties of Stable ZnS:Cu,Cl Nanocrystals. J. Phys. Chem. A 2009, 113,3830-3839.
    連結:
  16. 17. Voura EB, Jaiswal JK, Mattoussi H, Simon SM: Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat. Med. 2004, 10,993-998.
    連結:
  17. 18. Ung Thi Dieu T, Nguyen Quang L, Do Xuan T, Protiere M, Reiss P: Optical transitions in polarized CdSe, CdSe/ZnSe, and CdSe/CdS/ZnS quantum dots dispersed in various polar solvents. Appl. Phys. Lett. 2007, 91,241908-241901-241908-241908-241903.
    連結:
  18. 19. Choi AO, Brown SE, Szyf M, Maysinger D: Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells. J. Mol. Med. 2008, 86,291-302.
    連結:
  19. 20. Weng JF, Ren JC: Luminescent quantum dots: A very attractive and promising tool in biomedicine. Curr. Med. Chem. 2006, 13,897-909.
    連結:
  20. 21. Guo CX, Boullanger P, Jiang L, Liu T: Highly sensitive gold nanoparticles biosensor chips modified with a self-assembled bilayer for detection of Con A. Biosens. Bioelectron. 2007, 22,1830-1834.
    連結:
  21. 22. Hu M, Chen JY, Li ZY, Au L, Hartland GV, Li XD, Marquez M, Xia YN: Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev. 2006, 35,1084-1094.
    連結:
  22. 23. Jiang ZL, Zou MJ, Liang AH: An immunonanogold resonance scattering spectral probe for rapid assay of human chorionic gonadotrophin. Clin. Chim. Acta 2008, 387,24-30.
    連結:
  23. 24. Zhang W, Yang T, Jiang C, Jiao K: DNA hybridization and phosphinothricin acetyltransferase gene sequence detection based on zirconia/nanogold film modified electrode. Appl. Surf. Sci. 2008, 254,4750-4756.
    連結:
  24. 25. Liu T, Tang Ja, Jiang L: The enhancement effect of gold nanoparticles as a surface modifier on DNA sensor sensitivity. 2004, 313,3-7.
    連結:
  25. 26. Isaji S, Bin YZ, Matsuo M: Electrical conductivity and self-temperature-control heating properties of carbon nanotubes filled polyethylene films. Polymer 2009, 50,1046-1053.
    連結:
  26. 27. Supronowicz PR, Ajayan PM, Ullmann KR, Arulanandam BP, Metzger DW, Bizios R: Novel current-conducting composite substrates for exposing osteoblasts to alternating current stimulation. J. Biomed. Mater. Res. 2002, 59,499-506.
    連結:
  27. 28. Yang Z, Chen XH, Xia SZ, Pu YX, Xu HY, Li WH, Xu LS, Yi B, Pan WY: Covalent attachment of poly (acrylic acid) onto multiwalled carbon nanotubes functionalized with formaldehyde via electrophilic substitution reaction. J. Mater. Sci. 2007, 42,9447-9452.
    連結:
  28. 29. Harrison BS, Atala A: Carbon nanotube applications for tissue engineering. Biomaterials 2007, 28,344-353.
    連結:
  29. 30. Hirano S, Kanno S, Furuyama A: Multi-walled carbon nanotubes injure the plasma membrane of macrophages. Toxicol. Appl. Pharmacol. 2008, 232,244-251.
    連結:
  30. 31. Dong J, Xu ZH, Kuznicki SM: Magnetic Multi-Functional Nano Composites for Environmental Applications. Adv. Funct. Mater. 2009, 19,1268-1275.
    連結:
  31. 32. Hsiao JK, Tai MF, Chu HH, Chen ST, Li H, Lai DM, Hsieh ST, Wang JL, Liu HM: Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: Cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level. Magn. Reson. Med. 2007, 58,717-724.
    連結:
  32. 33. Jin X, Zhao Y, Richardson A, Moore L, Williams PS, Zborowski M, Chalmers JJ: Differences in magnetically induced motion of diamagnetic, paramagnetic, and superparamagnetic microparticles detected by cell tracking velocimetry. Analyst 2008, 133,1767-1775.
    連結:
  33. 34. Fuh CB, Su YS, Tsai HY: Determination of magnetic susceptibility of various ion-labeled red blood cells by means of analytical magnetophoresis. In 26th International Symposium on Capillary Chrmatography and Electrophoresis May 18-22; Las Vegas, Nevada: Elsevier Science Bv: 2003:289-296.
    連結:
  34. 35. He J, VanBrocklin HF, Franc BL, Seo Y, Jones EF: Nanoprobes for medical diagnosis: Current status of nanotechnology in molecular imaging. Curr. Nanosci. 2008, 4,17-29.
    連結:
  35. 36. Drake P, Cho HJ, Shih PS, Kao CH, Lee KF, Kuo CH, Lin XZ, Lin YJ: Gd-doped iron-oxide nanoparticles for tumour therapy via magnetic field hyperthermia. J. Mater. Chem. 2007, 17,4914-4918.
    連結:
  36. 37. Krueger A: New carbon materials: Biological applications of functionalized nanodiamond materials. Chem.-Eur. J. 2008, 14,1382-1390.
    連結:
  37. 38. Chang HC, Chen KW, Kwok S: Nanodiamond as a possible carrier of extended red emission. Astrophys. J. 2006, 639,L63-L66.
    連結:
  38. 39. Yu SJ, Kang MW, Chang HC, Chen KM, Yu YC: Bright fluorescent nanodiamonds: No photobleaching and low cytotoxicity. J. Am. Chem. Soc. 2005, 127,17604-17605.
    連結:
  39. 40. Chao J-I, Perevedentseva E, Chung P-H, Liu K-K, Cheng C-Y, Chang C-C, Cheng C-L: Nanometer-Sized Diamond Particle as a Probe for Biolabeling. 2007, 93,2199-2208.
    連結:
  40. 41. Fu CC, Lee HY, Chen K, Lim TS, Wu HY, Lin PK, Wei PK, Tsao PH, Chang HC, Fann W: Characterization and application of single fluorescent nanodiamonds as cellular biomarkers. Proc. Natl. Acad. Sci. U. S. A. 2007, 104,727-732.
    連結:
  41. 43. Glinka YD, Lin KW, Chang HC, Lin SH: Multiphoton-excited luminescence from diamond nanoparticles. J. Phys. Chem. B 1999, 103,4251-4263.
    連結:
  42. 44. Chang CC, Chen PH, Chu HL, Lee TC, Chou CC, Chao JI, Su CY, Chen JS, Tsai JS, Tsai CM, et al.: Laser induced popcornlike conformational transition of nanodiamond as a nanoknife. Appl. Phys. Lett. 2008, 93,3.
    連結:
  43. 45. Huang SN, Liu C, Dai GP, Kim YR, Rosen BR: Manipulation of tissue contrast using contrast agents for enhanced MR microscopy in ex vivo mouse brain. Neuroimage 2009, 46,589-599.
    連結:
  44. 46. Burdette JH, Elster AD, Ricci PE: Acute cerebral infarction: Quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology 1999, 212,333-339.
    連結:
  45. 47. Konig CW, Trubenbach J, Fritz J, Lauer UM, Claussen CD, Pereira PL: Contrast enhanced MR-guided biopsy of hepatocellular carcinoma. Abdom. Imaging 2004, 29,71-76.
    連結:
  46. 48. Trivedi RA, Mallawarachi C, U-King-Im JM, Graves MJ, Horsley J, Goddard MJ, Brown A, Wang LQ, Kirkpatrick PJ, Brown J, et al.: Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler. Thromb. Vasc. Biol. 2006, 26,1601-1606.
    連結:
  47. 49. Zech SG, Eldredge HB, Lowe MP, Caravan P: Protein binding to lanthanide(III) complexes can reduce the water exchange rate at the lanthanide. Inorg. Chem. 2007, 46,3576-3584.
    連結:
  48. 50. Zhang EY, Shu CY, Feng L, Wang CR: Preparation and characterization of two new water-soluble endohedral metallofullerenes as magnetic resonance imaging contrast agents. J. Phys. Chem. B 2007, 111,14223-14226.
    連結:
  49. 51. Sitharaman B, Tran LA, Pham QP, Bolskar RD, Muthupillai R, Flamm SD, Mikos AG, Wilson LJ: Gadofullerenes as nanoscale magnetic labels for cellular MRI. Contrast Media Mol. Imaging 2007, 2,139-146.
    連結:
  50. 52. Cheng FY, Wang SPH, Su CH, Tsai TL, Wu PC, Shieh DB, Chen JH, Hsieh PCH, Yeh CS: Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes. Biomaterials 2008, 29,2104-2112.
    連結:
  51. 53. Shih-Peng T, Tsung-Han T, Wen-Jeng L, Dar-Bin S, Yi-Hua L, Hsin-Yi H, Zhang KYJ, Hsiang-Lin L, Chi-Kuang S: Optical biopsy of fixed human skin with backward-collected optical harmonics signals. Opt. Express 2005, 13.
    連結:
  52. 54. Tai SP, Wu Y, Shieh DB, Chen LJ, Lin KJ, Yu CH, Chu SW, Chang CH, Shi XY, Wen YC, et al.: Molecular imaging of cancer cells using plasmon-resonant-enhanced third-harmonic-generation in silver nanoparticles. Adv. Mater. 2007, 19,4520-+.
    連結:
  53. 55. Olsson E, Forsberg F: Three-dimensional selective imaging of sound sources. Opt. Eng. 2009, 48,035801 (035808 pp.)-035801 (035808 pp.).
    連結:
  54. 57. Wang XD, Ku G, Wegiel MA, Bornhop DJ, Stoica G, Wang LHV: Noninvasive photoacoustic angiography of animal brains in vivo with near-infrared light and an optical contrast agent. Opt. Lett. 2004, 29,730-732.
    連結:
  55. 58. Larina IV, Larin KV, Esenaliev RO: Real-time optoacoustic monitoring of temperature in tissues. J. Phys. D-Appl. Phys. 2005, 38,2633-2639.
    連結:
  56. 60. Petrova IY, Esenaliev RO, Petrov YY, Brecht HPE, Svensen CH, Olsson J, Deyo DJ, Prough DS: Optoacoustic monitoring of blood hemoglobin concentration: a pilot clinical study. Opt. Lett. 2005, 30,1677-1679.
    連結:
  57. 61. Xiang LZ, Xing D, Gu HM, Yang DW, Yang SH, Zeng LM, Chen WR: Real-time optoacoustic monitoring of vascular damage during photodynamic therapy treatment of tumor. J. Biomed. Opt. 2007, 12,8.
    連結:
  58. 62. Yang CY, Wei CW, Lin YP, Tseng HC, Wu YN, Chen CC, Shieh DB, Li PC: Applications of carbohydrate-gold nanoparticles for volumetric flow measurements using an opto-acoustic technique. J. Chin. Chem. Soc. 2008, 55,103-108.
    連結:
  59. 63. Daoud SS, Munson PJ, Reinhold W, Young L, Prabhu VV, Yu QA, LaRose J, Kohn KW, Weinstein JN, Pommier Y: Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: A pharmacogenomic study. Cancer Res. 2003, 63,2782-2793.
    連結:
  60. 64. Kanerva A, Zinn KR, Chaudhuri TR, Lam JT, Suzuki K, Uil TG, Hakkarainen T, Bauerschmitz GJ, Wang MH, Liu B, et al.: Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Mol. Ther. 2003, 8,449-458.
    連結:
  61. 65. Tsai CM, Levitzki A, Wu LH, Chang KT, Cheng CC, Gazit A, Perng RP: Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells. Cancer Res. 1996, 56,1068-1074.
    連結:
  62. 66. Park CC, Zhang H, Paravicini M, Gray JW, Baehner F, Park CJ, Bissell MJ: beta(1) integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res. 2006, 66,1526-1535.
    連結:
  63. 67. Streit M, Detmar M: Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene 2003, 22,3172-3179.
    連結:
  64. 68. Tsai CM, Chang KT, Li L, Perng RP, Yang LY: Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells. Jpn. J. Cancer Res. 2000, 91,213-222.
    連結:
  65. 70. Zhuang W, Prohofsky EW: HOT PHONON-INDUCED BOND BREAKING - APPLICATION TO THE ADVANCE OF A REPLICATING FORK IN DNA. Phys. Rev. Lett. 1993, 71,2150-2153.
    連結:
  66. 71. Eriksson JE: REGULATION OF APOPTOSIS IN THE FEMALE REPRODUCTIVE SYSTEM. 2002.
    連結:
  67. 72. Allen RT, Hunter WJ, Agrawal DK: Morphological and biochemical characterization and analysis of apoptosis. J. Pharmacol. Toxicol. Methods 1997, 37,215-228.
    連結:
  68. 73. Sidhu RS, Tuor UI, DelBigio MR: Nuclear condensation and fragmentation following cerebral hypoxia-ischemia occurs more frequently in immature than older rats. Neurosci. Lett. 1997, 223,129-132.
    連結:
  69. 74. Collins JA, Schandl CA, Young KK, Vesely J, Willingham MC: Major DNA fragmentation is a late event in apoptosis. J. Histochem. Cytochem. 1997, 45,923-934.
    連結:
  70. 75. Reed JC: Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat. Clin. Pract. Oncol. 2006, 3,388-398.
    連結:
  71. 76. Reed JC, Doctor K, Rojas A, Zapata JM, Stehlik C, Fiorentino L, Damiano J, Roth W, Matsuzawa S, Newman R, et al.: Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res. 2003, 13,1376-1388.
    連結:
  72. 77. Liu K-K, Wang C-C, Cheng C-L, Chao J-I: Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells. In Press, Corrected Proof.
    連結:
  73. 78. Zhu T, Goh ELK, Graichen R, Ling L, Lobie PE: Signal transduction via the growth hormone receptor. Cell. Signal. 2001, 13,599-616.
    連結:
  74. 79. Kopchick JJ, Andry JM: Growth Hormone (GH), GH Receptor, and Signal Transduction. 2000, 71,293-314.
    連結:
  75. 80. Lee LTO, Nong G, Chan YH, Tse DLY, Cheng CHK: Molecular cloning of a teleost growth hormone receptor and its functional interaction with human growth hormone. Gene 2001, 270,121-129.
    連結:
  76. 81. Roch GJ, Wu S, Sherwood NM: Hormones and receptors in fish: Do duplicates matter? 2009, 161,3-12.
    連結:
  77. 82. Chang C-C, Tsai C-T, Chang C-Y: Structural restoration of inactive recombinant fish growth hormones by chemical chaperonin and solvent restraint approaches. 2002, 15,437-441.
    連結:
  78. 83. Houjin H, Pierstorff E, Osawa E, Ho D: Protein-mediated assembly of nanodiamond hydrogels into a biocompatible and biofunctional multilayer nanofilm. ACS Nano 2008, 2,203-212.
    連結:
  79. 84. Houjin H, Pierstorff E, Osawa E, Ho D: Active nanodiamond hydrogels for chemotherapeutic delivery. Nano Lett. 2007, 7,3305-3314.
    連結:
  80. 85. Liu KK, Cheng CL, Chang CC, Chao JI: Biocompatible and detectable carboxylated nanodiamond on human cell. Nanotechnology 2007, 18,10.
    連結:
  81. 86. Cheng CY, Perevedentseva E, Tu JS, Chung PH, Cheng CL, Liu KK, Chao JI, Chen PH, Chang CC: Direct and in vitro observation of growth hormone receptor molecules in A549 human lung epithelial cells by nanodiamond labeling. Appl. Phys. Lett. 2007, 90,3.
    連結:
  82. 87. Saxena A, Jacobson J, Yamanashi W, Scherlag B, Lamberth J, Saxena B: A hypothetical mathematical construct explaining the mechanism of biological amplification in an experimental model utilizing picoTesla (PT) electromagnetic fields. Med. Hypotheses 2003, 60,821-839.
    連結:
  83. 88. Gao Y, Prohofsky EW: A MODIFIED SELF-CONSISTENT PHONON THEORY OF HYDROGEN-BOND MELTING. J. Chem. Phys. 1984, 80,2242-2243.
    連結:
  84. 89. Gao SW: Quantum kinetic theory of vibrational heating and bond breaking by hot electrons. Phys. Rev. B 1997, 55,1876-1886.
    連結:
  85. 90. Chang C-C, Yeh X-C, Lee H-T, Lin P-Y, Kan L-S: Refolding of lysozyme by quasistatic and direct dilution reaction paths: A first-order-like state transition. 2004, 70,011904.
    連結:
  86. 91. Chang CC, Su YC, Cheng MS, Kan LS: Protein folding by a quasi-static-like process: A first-order state transition. Phys. Rev. E 2002, 66,8.
    連結:
  87. 92. Poniewierski A, Holyst R, Price AC, Sorensen LB, Kevan SD, Toner J: Dynamic correlation functions for finite and infinite smectic-A systems: Theory and experiment. Phys. Rev. E 1998, 58,2027-2040.
    連結:
  88. 93. Kim S, Kim CA, Choi YH, Jung MY: Synthesis of Polystyrene Nanoparticles with Different Surface Modification by Emulsion Polymerization and Measurement of IgG Adsorption and Stability for the Application in Latex-Protein Complex Based Solid-Phase Immunoassay. 2009, 62,23-32.
    連結:
  89. 95. Grabarek Z, Gergely J: ZERO-LENGTH CROSSLINKING PROCEDURE WITH THE USE OF ACTIVE ESTERS. Anal. Biochem. 1990, 185,131-135.
    連結:
  90. 98. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, Zamzami N, Mak T, Jaattela M, Penninger JM, Garrido C, et al.: Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 2001, 3,839-843.
    連結:
  91. 99. Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N, Kroemer G: Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. 84,215-222.
    連結:
  92. 100. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, et al.: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397,441-446.
    連結:
  93. 102. Yu SW, Wang HM, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002, 297,259-263.
    連結:
  94. 103. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS, Kroemer G, et al.: Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 2002, 158,507-517.
    連結:
  95. 104. Ahn HJ, Kim YS, Kim JU, Han SM, Shin JW, Yang HO: Mechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cells. J. Cell. Biochem. 2004, 91,1043-1052.
    連結:
  96. 105. BurkeGaffney A, Hellewell PG: Tumour necrosis factor-alpha-induced ICAM-1 expression in human vascular endothelial and lung epithelial cells: Modulation by tyrosine kinase inhibitors. Br. J. Pharmacol. 1996, 119,1149-1158.
    連結:
  97. 106. Babbar N, Hacker A, Huang Y, Casero RA: Tumor necrosis factor alpha induces spermidine/spermine N-1-acetyltransferase through nuclear factor kappa B in non-small cell lung cancer cells. J. Biol. Chem. 2006, 281,24182-24192.
    連結:
  98. 108. Ilvesmaki V, Kahri AI, Miettinen PJ, Voutilainen R: INSULIN-LIKE GROWTH-FACTORS (IGFS) AND THEIR RECEPTORS IN ADRENAL-TUMORS - HIGH IGF-II EXPRESSION IN FUNCTIONAL ADRENOCORTICAL CARCINOMAS. J. Clin. Endocrinol. Metab. 1993, 77,852-858.
    連結:
  99. 109. Reubi JC, Waser B, Vale W, Rivier J: Expression of CRF1 and CRF2 receptors in human cancers. J. Clin. Endocrinol. Metab. 2003, 88,3312-3320.
    連結:
  100. 110. Florio P, Franchini A, Reis FM, Pezzani I, Ottaviani E, Petraglia F: Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA. Placenta 2000, 21,32-37.
    連結:
  101. 111. Gschwind A, Fischer OM, Ullrich A: Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 2004, 4,361-370.
    連結:
  102. 113. Hynes NE, Lane HA: ERBB receptors and cancer: The complexity of targeted inhibitors. Nat. Rev. Cancer 2005, 5,341-354.
    連結:
  103. 114. Resnick MB, Routhier J, Konkin T, Sabo E, Pricolo VE: Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: A tissue microarray study. Clin. Cancer Res. 2004, 10,3069-3075.
    連結:
  104. 115. Hu WG, Liu T, Xiong JX, Wang CY: Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells. Acta Pharmacol. Sin. 2007, 28,1224-1230.
    連結:
  105. 116. Kauma S, Hayes N, Weatherford S: The differential expression of hepatocyte growth factor and Met in human placenta. J. Clin. Endocrinol. Metab. 1997, 82,949-954.
    連結:
  106. 117. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF: Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 2003, 4,915-925.
    連結:
  107. 118. Han SU, Lee HY, Lee JH, Kim WH, Nam H, Kim H, Cho YK, Kim MW, Lee KU: Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma. Ann. Surg. 2005, 242,676-683.
    連結:
  108. 119. Benyo DF, Conrad KP: Expression of the erythropoietin receptor by trophoblast cells in the human placenta. Biol. Reprod. 1999, 60,861-870.
    連結:
  109. 120. Acs G, Zhang PJ, Rebbeck TR, Acs P, Verma A: Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 2002, 95,969-981.
    連結:
  110. 121. Meunier-Carpentier S, Dales JP, Djemli A, Garcia S, Bonnier P, Andrac-Meyer L, Lavaut MN, Allasia C, Charpin C: Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. Int. J. Oncol. 2005, 26,977-984.
    連結:
  111. 122. Tseng JJ, Chou MM, Hsieh YT, Wen MC, Ho ESC, Hsu SL: Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta 2006, 27,70-78.
    連結:
  112. 124. Abdelrahim M, Baker CH, Abbruzzese JL, Sheikh-Hamad D, Liu SX, Cho SD, Yoon K, Safe S: Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells. Cancer Res. 2007, 67,3286-3294.
    連結:
  113. 125. Jokhi PP, King A, Jubinsky PT, Loke YW: DEMONSTRATION OF THE LOW-AFFINITY ALPHA-SUBUNIT OF THE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR (GM-CSF-R-ALPHA) ON HUMAN TROPHOBLAST AND UTERINE CELLS. J. Reprod. Immunol. 1994, 26,147-164.
    連結:
  114. 126. Yang X, Liu F, Xu Z, Chen C, Wu X, Li G, Li J: Expression of granulocyte colony stimulating factor receptor in human colorectal cancer. Postgrad. Med. J. 2005, 81,333-337.
    連結:
  115. 127. McCracken SA, Grant KE, MacKenzie IZ, Redman CWG, Mardon HJ: Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta. Biol. Reprod. 1999, 60,790-796.
    連結:
  116. 128. Fulop V, Mok SC, Genest DR, Szigetvari I, Cseh I, Berkowitz RS: c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins - Expression in normal placenta, partial and complete mole, and choriocarcinoma. J. Reprod. Med. 1998, 43,101-110.
    連結:
  117. 129. Jokhi PP, Chumbley G, King A, Gardner L, Loke YW: EXPRESSION OF THE COLONY STIMULATING FACTOR-I RECEPTOR (C-FMS PRODUCT) BY CELLS AT THE HUMAN UTEROPLACENTAL INTERFACE. Lab. Invest. 1993, 68,308-320.
    連結:
  118. 130. Gurski MR, Gonzalez E, Brown EG: Immunochemical localization of platelet-derived growth factor in placenta and its possible role in pre-eclampsia. J. Invest. Med. 1999, 47,128-133.
    連結:
  119. 131. Sugihara A, Maeda O, Tsuji M, Tsujimura T, Nakata Y, Akedo H, Kotake T, Terada N: Expression of cytokines enhancing the osteoclast activity, and parathyroid hormone-related protein in prostatic cancers before and after endocrine therapy: An immunohistochemical study. Oncol. Rep. 1998, 5,1389-1394.
    連結:
  120. 132. Sapi E: The role of CSF-1 in normal physiology of mammary gland and breast cancer: An update. Exp. Biol. Med. 2004, 229,1-11.
    連結:
  121. 134. Nixon T, Green H: PROPERTIES OF GROWTH-HORMONE RECEPTORS IN RELATION TO THE ADIPOSE CONVERSION OF 3T3-CELLS. J. Cell. Physiol. 1983, 115,291-296.
    連結:
  122. 135. Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F: Overexpression of platelet-derived growth factor receptor a in breast cancer is associated with tumour progression. Breast Cancer Res. 2005, 7,R788-R795.
    連結:
  123. 136. Zou LL, Burmeister LA, Sperling MA: Isolation of a liver-specific promoter for human growth hormone receptor gene. Endocrinology 1997, 138,1771-1774.
    連結:
  124. 137. de Mello-Coelho V, Gagnerault MC, Souberbielle JC, Strasburger CJ, Savino W, Dardenne M, Postel-Vinay MC: Growth hormone and its receptor are expressed in human thymic cells. Endocrinology 1998, 139,3837-3842.
    連結:
  125. 140. Wagner K, Hemminki K, Grzybowska E, Bermejo JL, Butkiewicz D, Pamula J, Pekala W, Forsti A: Polymorphisms in the growth hormone receptor: A case-control study in breast cancer. Int. J. Cancer 2006, 118,2903-2906.
    連結:
  126. 141. Ginarte A, Garcia-Caballero T, Fernandez-Redondo V, Beiras A, Toribio J: Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities. J. Cutan. Pathol. 2000, 27,276-282.
    連結:
  127. 142. Kong XL, Huang LCL, Hsu CM, Chen WH, Han CC, Chang HC: High-affinity capture of proteins by diamond nanoparticles for mass spectrometric analysis. Anal. Chem. 2005, 77,259-265.
    連結:
  128. 143. Chan ECY, Ho PC: Preparation and characterization of immunogens for antibody production against metanephrine and normetanephrine. 2002, 266,143-154.
    連結:
  129. 144. Roche AS: Cell Proliferation Kit I (MTT).
    連結:
  130. 4. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, et al.: Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. 2005.
  131. 42. Amanda M. Schrand HH, Cataleya Carlson, John J. Schlager, Eiji Oh sawa,, Dai SMHaL: Are Diamond Nanoparticles Cytotoxic? 2007, 111,2-7.
  132. 56. Esenaliev RO, Karabutov AA, Tittel FK, Fornage BD, Thomsen SL, Stelling C, Oraevsky AA: Laser optoacoustic imaging for breast cancer diagnostics: Limit of detection and comparison with X-ray and ultrasound imaging. In Conference on Optical Tomography and Spectroscopy of Tissue - Theory, Instrumentation, Model, and Human Studies II Feb 09-12; San Jose, Ca,Edited by Chance B, Alfano RR: Spie - Int Soc Optical Engineering: 1997:71-82.
  133. 59. Wang XD, Ku G, Xie XY, Wang YW, Stoica G, Wang LV: Non-invasive functional photoacoustic tomography of blood oxygen saturation in the brain. In Conference on Photons Plus Ultrasound Jan 25-26; San Jose, CA,Edited by Oraevsky AA, Wang LV: Spie-Int Soc Optical Engineering: 2004:69-76.
  134. 69. Willett CG, Duda DG, Czito BG, Bendell JC, Clark JW, Jain RK: Targeted therapy in rectal cancer. Oncology-NY 2007, 21,1055-1065.
  135. 94. Promega c: CellTiter 96 aqueous one soluteion cell prolixferation assay.
  136. 96. amaxa: Optimized Protocol for A549 cell line.7.
  137. 97. 陳家全、李家維、楊瑞森: 生物電子顯微鏡學. 1991.
  138. 101. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CYJ, Sasaki T, Elia AJ, Cheng HYM, Ravagnan L, et al.: Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001, 410,549-554.
  139. 107. Jones CJP, Hartmann M, Blaschitz A, Desoye G: ULTRASTRUCTURAL-LOCALIZATION OF INSULIN-RECEPTORS IN HUMAN PLACENTA. In 40th Annual Meeting of the Society-for-Gynecologic-Investigation Mar 31-Apr 03; Toronto, Canada: Munksgaard Int Publ Ltd: 1993:136-145.
  140. 112. Maruo T, Matsuo H, Otani T, Mochizuki M: Role of epidermal growth factor (EGF) and its receptor in the development of the human placenta. In 1st International Meeting of World Placenta Associations Oct 24-28; Sydney, Australia: C S I R O Publications: 1994:1465-1470.
  141. 123. Rivas CI, Vera JC, Delgado-Lopez F, Heaney ML, Guaiquil VH, Zhang RH, Scher HI, Concha, II, Nualart F, Cordon-Cardo C, et al.: Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer. Blood 1998, 91,1037-1043.
  142. 133. Smith HO, Anderson PS, Kuo DYS, Goldberg GL, Devictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW: THE ROLE OF COLONY-STIMULATING FACTOR-1 AND ITS RECEPTOR IN THE ETIOPATHOGENESIS OF ENDOMETRIAL ADENOCARCINOMA. Clin. Cancer Res. 1995, 1,313-325.
  143. 138. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM, et al.: Gene expression predictors of breast cancer outcomes. Lancet 2003, 361,1590-1596.
  144. 139. Dy DY, Whitehead RH, Morris DL: SMS-201.995 INHIBITS INVITRO AND INVIVO GROWTH OF HUMAN COLON CANCER. Cancer Res. 1992, 52,917-923.
Times Cited
  1. 李佳叡(2016)。奈米鑽石/環氧樹脂複合材料之分散性與機械特性研究。清華大學動力機械工程學系學位論文。2016。1-75。